The GSEA indicated that the immune-related lncRNA signature was mainly enriched in the complement and coagulation cascades, extracellular matrix (ECM) receptor interaction, focal adhesion, hedgehog signaling pathway, mitogen-activated protein kinase (MAPK) signaling pathway, notch signaling pathway, pathways in cancer and Wnt signaling pathway in the high-risk patients (Figure 5A) and the main citrate cycle, tricarboxylic acid cycle, porphyrin and chlorophyll metabolism, steroid biosynthesis, and terpenoid backbone biosynthesis in the low-risk patients (Figure 5B). The gene discussed is WNK2; the disease is cancer.